Dalbavancin in Bone and Joint Infections: A Systematic Review.
Sofia LovattiGiorgio TieccoAlice MuléLuca RossiAnita SforzaMartina SalviLiana SignoriniFrancesco CastelliEugenia Quiros-RoldanPublished in: Pharmaceuticals (Basel, Switzerland) (2023)
DBV has shown to be effective as a treatment for OA infections. The most favourable outcome was found in patients receiving three doses of DBV and with an adequate surgical management prior to antibiotic treatment. Although a rigorous administration schedule does not exist, DBV is a viable treatment option in the management of OA infections.
Keyphrases